ABBOTT LABORATORIES
ABTNext catalyst
Modified FOLFIRINOX
Locally Advanced Pancreatic Adenocarcinoma
Get an email about ABT's next catalysts
Track ABBOTT LABORATORIES (ABT) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 1 past
Modified FOLFIRINOX Phase 2 Est. Readout
Primary completion for Modified FOLFIRINOX trial (NCT06850623) in Locally Advanced Pancreatic Adenocarcinoma
SourceMarket Overview
Stock performance and key metrics
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States (13% of 2024 revenues), diagnostic products (20% of 2024 revenues), nutritional products (22% of 2024 revenues), and medical devices (45% of 2024 revenues).
WebsiteABT-712
Chronic Low Back Pain
Zemplar Capsule
Kidney Disease
clarithromycin extended-release tablets
Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB).
Ritonavir
Sarcoma, Kaposi
Lopinavir/ritonavir
HIV Infections
Asoprisnil
Uterine Fibroids
Mebeverine+Simethicone
Functional Bowel Disorder
Divalproex Sodium (Depakote ER)
Bipolar Disorder
ABT-335
Coronary Artery Disease
Lupron (leuprolide acetate)
Puberty, Precocious
Racecadotril plus ORS
Diarrhea, Infantile
sibutramine
Binge Eating Disorder
Palivizumab
Respiratory Syncytial Virus Infection
Nelfinavir mesylate
HIV Infections
lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs)
Human Immunodeficiency Virus Infections
paricalcitol capsules
End Stage Renal Disease
Sibutramine hydrochloride
Obesity
Hydrocodone/Acetaminophen Extended-Release
Pain
Hydrocodone/Acetaminophen Extended Release
Pain
atrasentan hydrochloride
Prostate Cancer
Divalproex Sodium (Depakote Sprinkle Capsules)
Partial Seizures
MTX
Psoriasis
Atrasentan
Prostate Cancer
Lamivudine
HIV Infections
lopinavir/ritonavir (LPV/r)
Human Immunodeficiency Virus Infection
Pancreatin
Pancreatic Insufficiency
fenofibrate
Hyperlipidemia
Eprosartan
Essential Hypertension
Human anti-TNF monoclonal antibody adalimumab/up to 24 weeks
Psoriasis
Micronized Progesterone
Female Infertility
Fixed Combination of Fenofibrate/simvastatin
Dyslipidemia
Itopride Hydrochloride
Functional Dyspepsia
Adalimumab subcutaneous every other week (EOW)
Rheumatoid Arthritis
ABT-267
Chronic Hepatitis C
Leuprolide acetate
Puberty, Precocious
paricalcitol capsule
Renal Insufficiency, Chronic
ABT-450/ritonavir
Hepatitis C
ABT-333
HCV Infection
Ademetionine IV+tablet
Intrahepatic Cholestasis Associated With Alcoholic Liver Disease
Leuprolide acetate - Formulation A
Prostate Cancer
Divalproex Sodium Extended-Release Tablets
Schizophrenia
SAMe
Non Alcoholic Fatty Liver Disease
dobutamine
Acute Heart Failure
Itopride (drug)
Functional Dyspepsia
lopinavir/ritonavir plus one nucleoside
HIV Infection
Divalproex Sodium ER
Bipolar Disorder
Tenofovir DF
HIV Infection
lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)
Human Immunodeficiency Virus Infections
Creon®
Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Phleum pratense grass pollen allergen extract
Seasonal Allergic Rhinitis
SA-001
Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
Niacin ER/Simvastatin Tablets
Hyperlipidemia
cefdinir
Acute Otitis Media
Nevirapine
HIV Infections
Humira (adalimumab)
Psoriasis
abacavir/3TC/zidovudine
AIDS-related Kaposi's Sarcoma
Anti-tumor necrosis factor alpha monoclonal antibody
Uveitis
Lopinavir/ritonavir (drug)
HIV Infections
AndroGel 5 Grams
Coronary Artery Disease
Adalimumab every other week
Plaque Psoriasis
Adalimumab Every Week
Plaque Psoriasis
Levodopa-carbidopa intestinal gel
Dyskinesias
Divalproex
Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania
Leuprolide acetate - Formulation B
Prostate Cancer
divalproex sodium extended release
Alcoholism
rosuvastatin calcium
Mixed Dyslipidemia
Maxacalcitol
Chronic Kidney Disease on Hemodialysis
Hydrocodone/Acetaminophen on Extended Release
Moderate to Severe Chronic, Non-malignant Pain
Celsentri®
HIV Infections
ABT-335 and simvastatin
Dyslipidemia
OLE FD Adalimumab +/- MTX
Arthritis, Juvenile Idiopathic
ABT-335 and atorvastatin calcium
Dyslipidemia
SKP FlutiForm HFA pMDI
Asthma
DB adalimumab eow
Crohn's Disease
Clarithromycin
Acute Bacterial Sinusitis (ABS)
adalimumab (Humira)
Ankylosing Spondylitis
Mitizax
Allergy
Amprenavir/ritonavir
HIV Infections
verapamil/trandolapril
Obesity
Leuprolide Acetate 3 Month Depot
Precocious
Influenza Vaccine
Influenza
ORS
Diarrhea
Saquinavir/ritonavir
HIV Infections
aspirin (ASA)
Dyslipidemia
Adalimumab eow or ew
Crohn's Disease
adalimumab
Chronic Plaque Psoriasis
Double-blind adalimumab
Rheumatoid Arthritis
Niacin extended-release (NER)
Dyslipidemia
ABT-335 and rosuvastatin calcium
Dyslipidemia
Human anti-TNF monoclonal antibody/adalimumab
Psoriatic Arthritis
paricalcitol
End-Stage Renal Disease
divalproex sodium
Migraine
Extended release hydrocodone and acetaminophen (Vicodin CR)
Chronic Low Back Pain
Elagolix
Heavy Uterine Bleeding
ABT-450/r/ABT-267, ABT-333
Chronic Hepatitis C Infection
Trivalent influenza subunit vaccine Influvac
Influenza
adalimumab (D2E7)
Ankylosing Spondylitis
Testosterone (T)
Hypogonadism
ABT-874
Psoriasis
Levosimendan
Heart Failure, Congestive
raltegravir (RAL)
Human Immunodeficiency Virus Infection
Kaletra Tablets
HIV Infections
metoprolol/HCT
Obesity
felodipine/ramipril
Obesity
OLE BSA Adalimumab +/- MTX
Arthritis, Juvenile Idiopathic
etanercept
Plaque Psoriasis
lamivudine/zidovudine
HIV Infection
Dydrogesterone
Recurrent Miscarriage
ABT-263
Small Cell Lung Cancer
Peginterferon alpha-2a
Hepatitis C
NBI-56418 (GnRH antagonist)
Endometriosis
ABT-639
Diabetic Neuropathic Pain
Combivir® (lamivudine, zidovudine)
HIV Infections
ABT-126
Cognitive Deficits in Schizophrenia
Extended-Release Hydrocodone/Acetaminophen
Pain
Depakote ER
Pediatric Epilepsy
Sustiva® (efavirenz)
HIV Infections
Veliparib
Brain Metastases From Non-small Cell Lung Cancer
Adalimumab, new formulation
Rheumatoid Arthritis
ABT-652
Osteoarthritis of the Knee
fenoldopam
Kidney Failure, Acute
Modified FOLFIRINOX
Locally Advanced Pancreatic Adenocarcinoma
Study Drug: Metformin
Metabolic Syndrome x
Anti IL-12 monoclonal antibody/ABT-874
Psoriasis
Valproic Acid (VPA)
Spinal Muscular Atrophy
Cell-Derived Trivalent Subunit Influenza Vaccine
Influenza
Pegylated interferon
Chronic Hepatitis C Virus Infection
Study Drug: fenofibrate
Metabolic Syndrome x
ABT-874/Human monoclonal antibody against IL-12
Multiple Sclerosis
Depakote Delayed-Release/Depakote Sprinkle
Pediatric Epilepsy
paricalcitol injection (Zemplar)
Hypocalcemia
Efavirenz
HIV Infections
M200 (Volociximab)
Ovarian Cancer, Primary Peritoneal Cancer
ABT-384
Alzheimer's Disease
pegylated interferon alpha-2a (pegIFN)
Chronic Hepatitis C
Kaletra® (lopinavir/ritonavir)
HIV Infections
Choline Fenofibrate
Diabetic Macular Edema
ABT-712 Extended-release
Pain
ABT-869 .25 mg/kg
Non-Small Cell Lung Cancer (NSCLC)
Navitoclax
Chronic Lymphocytic Leukemia
ABT-510 - Thrombospondin-1 mimetic
Sarcoma, Soft Tissue
ABT-450/r
Hepatitis C, Chronic
ABT-652 NSAID
Osteoarthritis of the Knee
New formulation adalimumab
Rheumatoid Arthritis
ABT-450
Chronic Hepatitis C Infection
ABT-SLV187
Advanced Parkinson's Disease
donepezil
Alzheimer's Disease
elotuzumab
Hematologic Cancer
ABT-869
Advanced or Metastatic Non-Small Cell Lung Cancer
(9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400
Dry Eye
Creon IR
Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
Asoprisnil/Premarin
Amenorrhea
Zemplar (paricalcitol) capsules
Diabetic Nephropathy
ABT-510/Thrombospondin-1 mimetic
Carcinoma, Renal Cell
ABT-888
Ovarian Cancer
Volociximab
Pancreatic Cancer
ABT-894
Attention-Deficit/Hyperactivity Disorder
Saquinavir mesylate
HIV Infections
Itopride HCI
Irritable Bowel Syndrome
ABT-288
Alzheimer's Disease
Study drugs: Metformin and fenofibrate
Metabolic Syndrome x
SLV337
Type 2 Diabetes
ABT-288 Low Dose
Cognitive Deficits in Schizophrenia
mFOLFOX-6
Metastatic Pancreatic Cancer
FITC-Adalimumab
Crohn's Disease
Adalimumab, current formulation
Rheumatoid Arthritis
Atrasentan low dose group
Chronic Kidney Disease
ABT-089
Attention-Deficit/Hyperactivity Disorder
ABT-751
Renal Cell Cancer
ABT-072
Hepatitis C
ABT-450/ritonavir, ABT-267
Chronic Hepatitis C Infection
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ABT-712 | Phase 3 | Chronic Low Back Pain | - | - |
Zemplar Capsule | Phase 3 | Kidney Disease | - | - |
clarithromycin extended-release tablets | Phase 3 | Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). | - | - |
Ritonavir | Phase 3 | Sarcoma, Kaposi | - | - |
Lopinavir/ritonavir | Phase 3 | HIV Infections | - | - |
Asoprisnil | Phase 3 | Uterine Fibroids | - | - |
Mebeverine+Simethicone | Phase 3 | Functional Bowel Disorder | - | - |
Divalproex Sodium (Depakote ER) | Phase 3 | Bipolar Disorder | - | - |
ABT-335 | Phase 3 | Coronary Artery Disease | - | - |
Lupron (leuprolide acetate) | Phase 3 | Puberty, Precocious | - | - |
Racecadotril plus ORS | Phase 3 | Diarrhea, Infantile | - | - |
sibutramine | Phase 3 | Binge Eating Disorder | - | - |
Palivizumab | Phase 3 | Respiratory Syncytial Virus Infection | - | - |
Nelfinavir mesylate | Phase 3 | HIV Infections | - | - |
lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs) | Phase 3 | Human Immunodeficiency Virus Infections | - | - |
paricalcitol capsules | Phase 3 | End Stage Renal Disease | - | - |
Sibutramine hydrochloride | Phase 3 | Obesity | - | - |
Hydrocodone/Acetaminophen Extended-Release | Phase 3 | Pain | - | - |
Hydrocodone/Acetaminophen Extended Release | Phase 3 | Pain | - | - |
atrasentan hydrochloride | Phase 3 | Prostate Cancer | - | - |
Divalproex Sodium (Depakote Sprinkle Capsules) | Phase 3 | Partial Seizures | - | - |
MTX | Phase 3 | Psoriasis | - | - |
Atrasentan | Phase 3 | Prostate Cancer | - | - |
Lamivudine | Phase 3 | HIV Infections | - | - |
lopinavir/ritonavir (LPV/r) | Phase 3 | Human Immunodeficiency Virus Infection | - | - |
Pancreatin | Phase 3 | Pancreatic Insufficiency | - | - |
fenofibrate | Phase 3 | Hyperlipidemia | - | - |
Eprosartan | Phase 3 | Essential Hypertension | - | - |
Human anti-TNF monoclonal antibody adalimumab/up to 24 weeks | Phase 3 | Psoriasis | - | - |
Micronized Progesterone | Phase 3 | Female Infertility | - | - |
Fixed Combination of Fenofibrate/simvastatin | Phase 3 | Dyslipidemia | - | - |
Itopride Hydrochloride | Phase 3 | Functional Dyspepsia | - | - |
Adalimumab subcutaneous every other week (EOW) | Phase 3 | Rheumatoid Arthritis | - | - |
ABT-267 | Phase 3 | Chronic Hepatitis C | - | - |
Leuprolide acetate | Phase 3 | Puberty, Precocious | - | - |
paricalcitol capsule | Phase 3 | Renal Insufficiency, Chronic | - | - |
ABT-450/ritonavir | Phase 3 | Hepatitis C | - | - |
ABT-333 | Phase 3 | HCV Infection | - | - |
Ademetionine IV+tablet | Phase 3 | Intrahepatic Cholestasis Associated With Alcoholic Liver Disease | - | - |
Leuprolide acetate - Formulation A | Phase 3 | Prostate Cancer | - | - |
Divalproex Sodium Extended-Release Tablets | Phase 3 | Schizophrenia | - | - |
SAMe | Phase 3 | Non Alcoholic Fatty Liver Disease | - | - |
dobutamine | Phase 3 | Acute Heart Failure | - | - |
Itopride (drug) | Phase 3 | Functional Dyspepsia | - | - |
lopinavir/ritonavir plus one nucleoside | Phase 3 | HIV Infection | - | - |
Divalproex Sodium ER | Phase 3 | Bipolar Disorder | - | - |
Tenofovir DF | Phase 3 | HIV Infection | - | - |
lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) | Phase 3 | Human Immunodeficiency Virus Infections | - | - |
Creon® | Phase 3 | Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis | - | - |
Phleum pratense grass pollen allergen extract | Phase 3 | Seasonal Allergic Rhinitis | - | - |
SA-001 | Phase 3 | Exocrine Pancreatic Insufficiency, Chronic Pancreatitis | - | - |
Niacin ER/Simvastatin Tablets | Phase 3 | Hyperlipidemia | - | - |
cefdinir | Phase 3 | Acute Otitis Media | - | - |
Nevirapine | Phase 3 | HIV Infections | - | - |
Humira (adalimumab) | Phase 3 | Psoriasis | - | - |
abacavir/3TC/zidovudine | Phase 3 | AIDS-related Kaposi's Sarcoma | - | - |
Anti-tumor necrosis factor alpha monoclonal antibody | Phase 3 | Uveitis | - | - |
Lopinavir/ritonavir (drug) | Phase 3 | HIV Infections | - | - |
AndroGel 5 Grams | Phase 3 | Coronary Artery Disease | - | - |
Adalimumab every other week | Phase 3 | Plaque Psoriasis | - | - |
Adalimumab Every Week | Phase 3 | Plaque Psoriasis | - | - |
Levodopa-carbidopa intestinal gel | Phase 3 | Dyskinesias | - | - |
Divalproex | Phase 3 | Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania | - | - |
Leuprolide acetate - Formulation B | Phase 3 | Prostate Cancer | - | - |
divalproex sodium extended release | Phase 3 | Alcoholism | - | - |
rosuvastatin calcium | Phase 3 | Mixed Dyslipidemia | - | - |
Maxacalcitol | Phase 3 | Chronic Kidney Disease on Hemodialysis | - | - |
Hydrocodone/Acetaminophen on Extended Release | Phase 3 | Moderate to Severe Chronic, Non-malignant Pain | - | - |
Celsentri® | Phase 3 | HIV Infections | - | - |
ABT-335 and simvastatin | Phase 3 | Dyslipidemia | - | - |
OLE FD Adalimumab +/- MTX | Phase 3 | Arthritis, Juvenile Idiopathic | - | - |
ABT-335 and atorvastatin calcium | Phase 3 | Dyslipidemia | - | - |
SKP FlutiForm HFA pMDI | Phase 3 | Asthma | - | - |
DB adalimumab eow | Phase 3 | Crohn's Disease | - | - |
Clarithromycin | Phase 3 | Acute Bacterial Sinusitis (ABS) | - | - |
adalimumab (Humira) | Phase 3 | Ankylosing Spondylitis | - | - |
Mitizax | Phase 3 | Allergy | - | - |
Amprenavir/ritonavir | Phase 3 | HIV Infections | - | - |
verapamil/trandolapril | Phase 3 | Obesity | - | - |
Leuprolide Acetate 3 Month Depot | Phase 3 | Precocious | - | - |
Influenza Vaccine | Phase 3 | Influenza | - | - |
ORS | Phase 3 | Diarrhea | - | - |
Saquinavir/ritonavir | Phase 3 | HIV Infections | - | - |
aspirin (ASA) | Phase 3 | Dyslipidemia | - | - |
Adalimumab eow or ew | Phase 3 | Crohn's Disease | - | - |
adalimumab | Phase 3 | Chronic Plaque Psoriasis | - | - |
Double-blind adalimumab | Phase 3 | Rheumatoid Arthritis | - | - |
Niacin extended-release (NER) | Phase 3 | Dyslipidemia | - | - |
ABT-335 and rosuvastatin calcium | Phase 3 | Dyslipidemia | - | - |
Human anti-TNF monoclonal antibody/adalimumab | Phase 3 | Psoriatic Arthritis | - | - |
paricalcitol | Phase 3 | End-Stage Renal Disease | - | - |
divalproex sodium | Phase 3 | Migraine | - | - |
Extended release hydrocodone and acetaminophen (Vicodin CR) | Phase 3 | Chronic Low Back Pain | - | - |
Elagolix | Phase 3 | Heavy Uterine Bleeding | - | - |
ABT-450/r/ABT-267, ABT-333 | Phase 3 | Chronic Hepatitis C Infection | - | - |
Trivalent influenza subunit vaccine Influvac | Phase 3 | Influenza | - | - |
adalimumab (D2E7) | Phase 3 | Ankylosing Spondylitis | - | - |
Testosterone (T) | Phase 3 | Hypogonadism | - | - |
ABT-874 | Phase 3 | Psoriasis | - | - |
Levosimendan | Phase 3 | Heart Failure, Congestive | - | - |
raltegravir (RAL) | Phase 3 | Human Immunodeficiency Virus Infection | - | - |
Kaletra Tablets | Phase 3 | HIV Infections | - | - |
metoprolol/HCT | Phase 3 | Obesity | - | - |
felodipine/ramipril | Phase 3 | Obesity | - | - |
OLE BSA Adalimumab +/- MTX | Phase 3 | Arthritis, Juvenile Idiopathic | - | - |
etanercept | Phase 3 | Plaque Psoriasis | - | - |
lamivudine/zidovudine | Phase 3 | HIV Infection | - | - |
Dydrogesterone | Phase 3 | Recurrent Miscarriage | - | - |
ABT-263 | Phase 2 | Small Cell Lung Cancer | - | - |
Peginterferon alpha-2a | Phase 2 | Hepatitis C | - | - |
NBI-56418 (GnRH antagonist) | Phase 2 | Endometriosis | - | - |
ABT-639 | Phase 2 | Diabetic Neuropathic Pain | - | - |
Combivir® (lamivudine, zidovudine) | Phase 2 | HIV Infections | - | - |
ABT-126 | Phase 2 | Cognitive Deficits in Schizophrenia | - | - |
Extended-Release Hydrocodone/Acetaminophen | Phase 2 | Pain | - | - |
Depakote ER | Phase 2 | Pediatric Epilepsy | - | - |
Sustiva® (efavirenz) | Phase 2 | HIV Infections | - | - |
Veliparib | Phase 2 | Brain Metastases From Non-small Cell Lung Cancer | - | - |
Adalimumab, new formulation | Phase 2 | Rheumatoid Arthritis | - | - |
ABT-652 | Phase 2 | Osteoarthritis of the Knee | - | - |
fenoldopam | Phase 2 | Kidney Failure, Acute | - | - |
Modified FOLFIRINOX | Phase 2 | Locally Advanced Pancreatic Adenocarcinoma | - | - |
Study Drug: Metformin | Phase 2 | Metabolic Syndrome x | - | - |
Anti IL-12 monoclonal antibody/ABT-874 | Phase 2 | Psoriasis | - | - |
Valproic Acid (VPA) | Phase 2 | Spinal Muscular Atrophy | - | - |
Cell-Derived Trivalent Subunit Influenza Vaccine | Phase 2 | Influenza | - | - |
Pegylated interferon | Phase 2 | Chronic Hepatitis C Virus Infection | - | - |
Study Drug: fenofibrate | Phase 2 | Metabolic Syndrome x | - | - |
ABT-874/Human monoclonal antibody against IL-12 | Phase 2 | Multiple Sclerosis | - | - |
Depakote Delayed-Release/Depakote Sprinkle | Phase 2 | Pediatric Epilepsy | - | - |
paricalcitol injection (Zemplar) | Phase 2 | Hypocalcemia | - | - |
Efavirenz | Phase 2 | HIV Infections | - | - |
M200 (Volociximab) | Phase 2 | Ovarian Cancer, Primary Peritoneal Cancer | - | - |
ABT-384 | Phase 2 | Alzheimer's Disease | - | - |
pegylated interferon alpha-2a (pegIFN) | Phase 2 | Chronic Hepatitis C | - | - |
Kaletra® (lopinavir/ritonavir) | Phase 2 | HIV Infections | - | - |
Choline Fenofibrate | Phase 2 | Diabetic Macular Edema | - | - |
ABT-712 Extended-release | Phase 2 | Pain | - | - |
ABT-869 .25 mg/kg | Phase 2 | Non-Small Cell Lung Cancer (NSCLC) | - | - |
Navitoclax | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
ABT-510 - Thrombospondin-1 mimetic | Phase 2 | Sarcoma, Soft Tissue | - | - |
ABT-450/r | Phase 2 | Hepatitis C, Chronic | - | - |
ABT-652 NSAID | Phase 2 | Osteoarthritis of the Knee | - | - |
New formulation adalimumab | Phase 2 | Rheumatoid Arthritis | - | - |
ABT-450 | Phase 2 | Chronic Hepatitis C Infection | - | - |
ABT-SLV187 | Phase 2 | Advanced Parkinson's Disease | - | - |
donepezil | Phase 2 | Alzheimer's Disease | - | - |
elotuzumab | Phase 2 | Hematologic Cancer | - | - |
ABT-869 | Phase 2 | Advanced or Metastatic Non-Small Cell Lung Cancer | - | - |
(9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400 | Phase 2 | Dry Eye | - | - |
Creon IR | Phase 2 | Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis | - | - |
Asoprisnil/Premarin | Phase 2 | Amenorrhea | - | - |
Zemplar (paricalcitol) capsules | Phase 2 | Diabetic Nephropathy | - | - |
ABT-510/Thrombospondin-1 mimetic | Phase 2 | Carcinoma, Renal Cell | - | - |
ABT-888 | Phase 2 | Ovarian Cancer | - | - |
Volociximab | Phase 2 | Pancreatic Cancer | - | - |
ABT-894 | Phase 2 | Attention-Deficit/Hyperactivity Disorder | - | - |
Saquinavir mesylate | Phase 2 | HIV Infections | - | - |
Itopride HCI | Phase 2 | Irritable Bowel Syndrome | - | - |
ABT-288 | Phase 2 | Alzheimer's Disease | - | - |
Study drugs: Metformin and fenofibrate | Phase 2 | Metabolic Syndrome x | - | - |
SLV337 | Phase 2 | Type 2 Diabetes | - | - |
ABT-288 Low Dose | Phase 2 | Cognitive Deficits in Schizophrenia | - | - |
mFOLFOX-6 | Phase 2 | Metastatic Pancreatic Cancer | - | - |
FITC-Adalimumab | Phase 2 | Crohn's Disease | - | - |
Adalimumab, current formulation | Phase 2 | Rheumatoid Arthritis | - | - |
Atrasentan low dose group | Phase 2 | Chronic Kidney Disease | - | - |
ABT-089 | Phase 2 | Attention-Deficit/Hyperactivity Disorder | - | - |
ABT-751 | Phase 2 | Renal Cell Cancer | - | - |
ABT-072 | Phase 2 | Hepatitis C | - | - |
ABT-450/ritonavir, ABT-267 | Phase 2 | Chronic Hepatitis C Infection | - | - |
preterm infant nutrition
1 drug in this indication
Chronic Low Back Pain
1 drug in this indication
Molecular residual disease (MRD) detection in colorectal cancer
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in ABBOTT LABORATORIES's drug pipeline?→
CatalystAlert tracks 171 drug candidates in ABBOTT LABORATORIES's (ABT) pipeline across Phase 3, Phase 2. Its lead program is abacavir/3TC/zidovudine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ABBOTT LABORATORIES's next FDA catalyst?→
ABBOTT LABORATORIES's (ABT) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ABT biotech catalysts?→
Add ABT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ABBOTT LABORATORIES's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.